News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
209 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22406)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (176)
2 (7)
3 (6)
4 (219)
5 (189)
6 (212)
7 (230)
8 (95)
9 (2)
10 (7)
11 (143)
12 (249)
13 (209)
14 (213)
15 (105)
16 (3)
17 (5)
18 (200)
19 (228)
20 (201)
21 (239)
22 (96)
23 (3)
24 (6)
25 (203)
26 (268)
27 (220)
28 (279)
29 (127)
30 (2)
31 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
FDA Greenlights Lilly Early Breast Cancer Drug - with a Caveat
The drug is limited to patients who test at least 20% for a Ki-67 score on an FDA-approved test.
October 13, 2021
·
2 min read
·
Mark Terry
Drug Development
Glimmers of Hope in MS as Genentech, Sanofi and Biogen Present at ECTRIMS
At the virtual Congress of the ECTRIMS meeting this week, multiple companies present data for ongoing studies of therapies for multiple sclerosis. BioSpace takes a look at some of the data.
October 13, 2021
·
4 min read
·
Alex Keown
Global Roundup: Singapore’s AUM Biosciences Earns $27 Million in Series A Round
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
October 13, 2021
·
7 min read
·
Alex Keown
FDA
FDA Experts: Case is Inconclusive for Moderna Vaccine Booster
The FDA said that there had been concerns over the reduced effectiveness of the Moderna COVID-19 vaccine against symptomatic disease.
October 13, 2021
·
2 min read
·
Vanessa Doctor, RN
Business
Takeda Doubles Down on Biotech Partnerships with Immusoft and Poseida
Seattle-based Immusoft announced it had inked a research pact and license option deal with Takeda to create, develop, and market cell therapies in rare inherited metabolic diseases with CNS manifestations and complications.
October 13, 2021
·
3 min read
·
Mark Terry
Career Advice
7 Job Hunting Tips to Avoid Mistakes While Searching For Jobs
You can follow these job hunting tips to optimize your job search and prefer finding the jobs that you want and not any irrelevant ones. Here’s how to do it.
October 13, 2021
·
4 min read
·
Hannah Harshman
Drug Development
CRISPR Therapeutics’ CAR-T Cancer Therapy Shows Early Promise
CRISPR Therapeutics provided updated data from its ongoing Phase I CARBON trial of CTX110, its allogeneic “off-the-shelf” CAR-T therapy for CD19+ B-cell cancers.
October 13, 2021
·
3 min read
·
Mark Terry
Policy
China Tests Blood Samples to Determine Virus Origins and More COVID-19 Research Updates
Research on the ever-evolving SARS-CoV-2 virus continues as scientists scramble to make sense of it and find cures. Here’s a look.
October 13, 2021
·
3 min read
·
Vanessa Doctor, RN
Drug Development
BrainStorm Gets Hopeful Window into NurOwn’s Effect on Progressive MS
BrainStorm announced positive data from a Phase II safety and efficacy study of NurOwn in progressive MS on Thursday morning.
October 13, 2021
·
3 min read
·
Heather McKenzie
Business
CinCor Raises $143 Million To Fund Innovation in Hypertension Research
A large part of the funding will go to the research and development of CIN-107 as it has shown the potential to treat primary aldosteronism and treatment-resistant hypertension.
October 13, 2021
·
2 min read
·
Vanessa Doctor, RN
1 of 21
Next